EcoDrugPlus

Cyclin-Dependent Kinase 2

Ensembl ID : ENSLCAG00010026017
Gene Symbol: CDK2
1 Cross references
199 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSLCAG00010020824
Gene Symbol: LOC108898964
4 Cross references
238 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSLCAG00010004830
Gene Symbol: LOC108883365
4 Cross references
169 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSLCAG00010019619
Gene Symbol: CDK6
1 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSLCAG00010028164
Gene Symbol: LOC108878776
4 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSLCAG00010011745
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSLCAG00010001742
Gene Symbol: LOC108882742
4 Cross references
172 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSLCAG00010003663
Gene Symbol: CDAB
4 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSLCAG00010023505
Gene Symbol: LOC108876786
4 Cross references
194 Possible Orthologues:

Cytochrome P450 3a27

Ensembl ID : ENSLCAG00010020633
Gene Symbol: LOC108877940
3 Cross references
445 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSLCAG00010019832
Gene Symbol: LOC108896255
4 Cross references
535 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSLCAG00010009554
Gene Symbol: CYP19A1
2 Cross references
244 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).